EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Myeloid Cells in Head and Neck Squamous Cell Carcinoma: A Kinase Inhibitor Library Screening Approach

Mohamed Y Zaky iD, Jessy John iD, Monika Vashisht, Priya Singh, Mohammad A I Al-Hatamleh iD, Karen Siddoway, Zhangguo Chen, Jing H Wang iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252212277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Mohamed Y Zaky und 7 weiteren Autor:innen. Beteiligte Einrichtung: UPMC Hillman Cancer Center, Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh School of Medicin…. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDCR NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck squamous cell carcinoma (HNSCC) is highly enriched with tumor-infiltrating myeloid cells, including tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs). However, effective therapeutic agents targeting tumor-associated myeloid cells in HNSCC are currently lacking. Here, we employed a unique co-culture system to investigate how HNSCC cells affect tumor-associated myeloid cells. We found that the presence of cancer cells significantly enhances myeloid cell proliferation and promotes TAM differentiation. To identify potential therapeutic agents, we screened a custom library of 70 kinase inhibitors to assess their effects on distinct subsets of tumor-associated myeloid cells. We discovered specific inhibitors that differentially suppressed the populations of TAMs, monocytic MDSCs (M-MDSCs), or polymorphonuclear MDSCs (PMN-MDSCs), suggesting that inhibiting different targets could reduce distinct subsets of tumor-associated myeloid cells. Conversely, some inhibitors were found to increase the population of CD11b+Ly6G−Ly6C− myeloid cells. Among the promising inhibitors tested, vatalanib, a VEGF-R inhibitor, demonstrated significant in vivo efficacy at inhibiting tumor growth and reducing tumor-associated myeloid cells, thereby underscoring its potential as a therapeutic agent. Our findings highlight specific kinase inhibitors with differential modulatory effects on HNSCC-associated myeloid subsets and caution the application of some as anti-cancer drugs. This experimental system may provide a robust platform for identifying new agents targeting tumor-associated myeloid cells in HNSCC and beyond, and for elucidating mechanistic insights into tumor-myeloid cell interaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Kinase InhibitorsSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsHumansAnimalsMiceCell Line, TumorCell ProliferationCoculture TechniquesMyeloid-Derived Suppressor CellsMyeloid CellsCell DifferentiationTumor-Associated MacrophagesXenograft Model Antitumor AssaysAntineoplastic Agents

Stichwörter der Autor:innen

head and neck squamous cell carcinomakinase inhibitorsmyeloid cellstherapeutic targetstumor microenvironmenttumor-associated macrophages

Substanzen

Protein Kinase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • UPMC Hillman Cancer Center, Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
  • Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.

ORCID-Profile: Mohamed Y Zaky, Jessy John, Mohammad A I Al-Hatamleh, Jing H Wang

Förderung

  • NCI NIH HHS
  • NIDCR NIH HHS
  • NIH HHS
  • NIH/NCI
  • UPMC Hillman Cancer Center startup fund
  • UPMC Hillman Cancer Center and a DRP award

Zitieren

APA

Zaky, M. Y., John, J., Vashisht, M., Singh, P., Al-Hatamleh, M. A. I., Siddoway, K., Chen, Z., & Wang, J. H. (2024). Targeting Myeloid Cells in Head and Neck Squamous Cell Carcinoma: A Kinase Inhibitor Library Screening Approach. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212277

Vancouver

Zaky MY, John J, Vashisht M, Singh P, Al-Hatamleh MAI, Siddoway K, et al. Targeting Myeloid Cells in Head and Neck Squamous Cell Carcinoma: A Kinase Inhibitor Library Screening Approach. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212277

BibTeX
@article{Zaky2024,
  author = {Zaky, Mohamed Y and John, Jessy and Vashisht, Monika and Singh, Priya and Al-Hatamleh, Mohammad A I and Siddoway, Karen and Chen, Zhangguo and Wang, Jing H},
  title = {Targeting Myeloid Cells in Head and Neck Squamous Cell Carcinoma: A Kinase Inhibitor Library Screening Approach},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252212277}
}
Kostenlos starten →